Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.
The Food and Drug Administration has approved a generic drug for leukemia made by a subsidiary of Par Pharmaceutical Cos.
A drug designed to reduce the risk of premature birth among pregnant women has been submitted to the Food and Drug Administration for approval.